ArticleScientific reports2025
Differential proteomics of interstitial fluid in lung tissue associated with the progression of pulmonary fibrosis in mice.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Recent advances in interstitial fluid dynamics for diagnostic, targeted drug delivery and precision medicine applications.Drug delivery and translational research · 2026Review
- Chlorogenic acid mitigates calcium oxalate monohydrate crystal-induced epithelial-to-mesenchymal transition in renal epithelial cells via suppression of HSP60 expression and p38 signaling.Cellular & molecular biology letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal fibrosis disease. Due to the limited understanding of its pathogenesis and the fact that its detection largely depends on the operator's technical level and the accuracy of the equipment, the diagnosis and treatment of the disease have significant limitations. In this research, bleomycin was used to establish IPF models of C57/BL6N mice with different injury degrees, and proteomics technology extracted interstitial fluid of lung tissue to analyze the mechanism of fibrosis at different stages. Compared with the normal group, the alveolar area, collagen deposition, tidal volume, and respiratory rate of the experimental group decreased at all periods, and the difference was most significant on the 14th day of modeling. Proteomic techniques, including gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, showed that the progression of pulmonary fibrosis was related to different pathways: glucose metabolism, lipid transport, glycoprotein metabolism, synthesis of sulfur compounds, and other energy metabolism, calcium ion transport were dominant in the early stage of fibrosis and the acute inflammatory stage. The endoplasmic reticulum stress pathway was dominant in the extreme stage of fibrosis, and blood flow shear stress, Extracellular matrix (ECM) receptor activation, and other extracellular matrix-related pathways were dominant in the late stage of fibrosis. Moreover, western bolt validation experiments also confirmed that C/EBP-homologous protein (CHOP), Heat Shock Protein 60 (HSP60), and Alpha smooth muscle actin(α-SMA) proteins were increased in expression related to this pathway at the extreme stage of fibrosis, suggesting that the disruption of ion balance in the endoplasmic reticulum induced by endoplasmic reticulum stress or the disturbance of protein processing and transportation were involved in the occurrence and development of pulmonary fibrosis in mice. The above results are expected to provide ideas for clinical interpretation of the mechanism of pulmonary fibrosis and provide vital data support for its accurate diagnosis and effective treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.